WASHINGTON TRUST Co Reduces Position in Axon Enterprise, Inc. (NASDAQ:AXON)

WASHINGTON TRUST Co cut its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 560 shares of the biotechnology company’s stock after selling 23 shares during the period. WASHINGTON TRUST Co’s holdings in Axon Enterprise were worth $333,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Vontobel Holding Ltd. boosted its position in Axon Enterprise by 58.6% in the 3rd quarter. Vontobel Holding Ltd. now owns 4,066 shares of the biotechnology company’s stock valued at $1,625,000 after buying an additional 1,503 shares during the period. Bleakley Financial Group LLC boosted its position in Axon Enterprise by 7.9% in the 3rd quarter. Bleakley Financial Group LLC now owns 1,507 shares of the biotechnology company’s stock valued at $602,000 after buying an additional 110 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Axon Enterprise by 2.0% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 7,391 shares of the biotechnology company’s stock valued at $2,953,000 after buying an additional 143 shares during the period. Stratos Wealth Advisors LLC purchased a new stake in Axon Enterprise in the 3rd quarter valued at about $259,000. Finally, Blue Trust Inc. boosted its position in Axon Enterprise by 234.5% in the 3rd quarter. Blue Trust Inc. now owns 291 shares of the biotechnology company’s stock valued at $116,000 after buying an additional 204 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have issued reports on AXON shares. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Needham & Company LLC upped their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Finally, TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $542.15.

Axon Enterprise Trading Up 2.8 %

Shares of Axon Enterprise stock opened at $683.41 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $260.27 and a 12-month high of $698.67. The firm has a market capitalization of $52.11 billion, a price-to-earnings ratio of 176.59, a PEG ratio of 6.79 and a beta of 1.05. The firm’s 50 day simple moving average is $623.22 and its two-hundred day simple moving average is $507.71.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the transaction, the insider now owns 128,542 shares in the company, valued at approximately $84,168,016.18. This represents a 1.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,711 shares of company stock worth $5,631,561. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.